全文获取类型
收费全文 | 999篇 |
免费 | 31篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 109篇 |
妇产科学 | 9篇 |
基础医学 | 49篇 |
口腔科学 | 22篇 |
临床医学 | 243篇 |
内科学 | 129篇 |
皮肤病学 | 34篇 |
神经病学 | 40篇 |
特种医学 | 17篇 |
外科学 | 132篇 |
综合类 | 55篇 |
预防医学 | 66篇 |
眼科学 | 4篇 |
药学 | 102篇 |
中国医学 | 19篇 |
肿瘤学 | 10篇 |
出版年
2023年 | 12篇 |
2022年 | 16篇 |
2021年 | 30篇 |
2020年 | 24篇 |
2019年 | 92篇 |
2018年 | 94篇 |
2017年 | 58篇 |
2016年 | 27篇 |
2015年 | 29篇 |
2014年 | 82篇 |
2013年 | 83篇 |
2012年 | 46篇 |
2011年 | 58篇 |
2010年 | 57篇 |
2009年 | 52篇 |
2008年 | 37篇 |
2007年 | 43篇 |
2006年 | 28篇 |
2005年 | 32篇 |
2004年 | 27篇 |
2003年 | 20篇 |
2002年 | 11篇 |
2001年 | 11篇 |
2000年 | 12篇 |
1999年 | 8篇 |
1998年 | 6篇 |
1997年 | 6篇 |
1996年 | 5篇 |
1995年 | 9篇 |
1994年 | 2篇 |
1993年 | 1篇 |
1991年 | 1篇 |
1989年 | 3篇 |
1986年 | 3篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1983年 | 3篇 |
1982年 | 5篇 |
1981年 | 3篇 |
1979年 | 1篇 |
1976年 | 2篇 |
排序方式: 共有1041条查询结果,搜索用时 15 毫秒
1.
2.
目的评价西地那非治疗ED的有效性。方法通过中国生物医学文摘光盘(CBMdisc 2004新版)和清华同方数据库中CHKD期刊全文库检索公开发表的中文文献。凡摘要或方法中出现随机对照字样,无论有无盲法均予纳入。对纳入的试验设计特征用Jadad计分评价。以IIEF中Q3和Q4评分及IIEF总评分为疗效指标,采用RevMan4.1软件进行Meta分析。结果共有9个随机对照试验被纳入。其中6个为Jadad计分3分以上高质量试验。5个试验的IIEF Q3和Q4评分meta分析,OR=8.83,95%CI为(6.67,11.69),P<0.0001。4个高质量试验的IIEF总评分meta分析OR=13.76,95%CI为(9.50,19.92),P<0.0001。显示西地那非能够显著提高ED患者的疗效指标。结论西地那非能有效改善男性勃起功能,是一种有效治疗ED的口服药物。 相似文献
3.
Gail D'Onofrio Edward Bernstein Judith Bernstein Robert H. Woolard Phillip A. Brewer Sandra A. Craig Brian J. Zink 《Academic emergency medicine》1998,5(12):1200-1209
Abstract. Medical and social problems related to alcohol use are frequently seen in the ED. Often, the tempo of emergency medicine practice seems to preclude assessment beyond that required by the acute complaint. However, detection of ED patients with alcohol problems can occur using brief screening tools. This article was developed by members of the SAEM Substance Abuse Task Force, and describes screening tools that have been used successfully to identify atrisk and dependent drinkers. Their brevity, reproducibility, and accuracy vary somewhat, but screening can be realistically performed in the busy ED setting. The early detection of patients with alcohol problems would provide the opportunity for early intervention, and may reduce subsequent morbidity and mortality in this patient population. 相似文献
4.
Seeliger F Drögemüller C Tegtmeier P Baumgärtner W Distl O Leeb T 《Journal of comparative pathology》2005,132(4):346-349
A 2-year-old German Holstein bull was identified as a carrier of a mutation within the X-chromosomal ED1 gene, which encodes a TNF-related signalling molecule mainly involved in ectodermal development. The clinicopathological appearance was associated with hypotrichosis, hypodontia, and a reduced number of eccrine glands, in addition to chronic rhinotracheitis and partial squamous metaplasia. Furthermore, for the first time in an ED1-deficient animal, a complete lack of respiratory mucous glands was observed. This suggests that the ED1 gene plays a role in the development of mucous glands, the absence of which resembles a feature of X-linked anhidrotic ectodermal dysplasia (ED1) in human patients. 相似文献
5.
目的 观察依托咪酯(etomidate,Eto)对布比卡因(bupivacaine,Bup)致惊厥作用及半数有效量(ED50)、半数致死量(LD50)的影响.方法 皮下注射3种不同剂量的依托咪酯20min后,腹腔注射致惊厥作用的布比卡因,观察小鼠惊厥潜伏期、持续时间、未惊厥数和死亡数;并以序贯法测定预先给予依托咪酯20min后布比卡因的致惊厥ED50和LD50.结果 依托咪酯2、4mg/kg可延长布比卡因致小鼠惊厥的潜伏期(P<0.01),缩短持续时间(P<0.01),减少惊厥发生数和死亡数;增大布比卡因致惊厥的ED50(P<0.05,P<0.01),增大布比卡因的LD50(P<0.01).结论 依托咪酯能够拮抗布比卡因的致惊厥作用,降低布比卡因的毒性. 相似文献
6.
7.
Anthony H Chavez K Scott Coffield M Hasan Rajab Chanhee Jo 《Asian journal of andrology》2013,15(2):246-248
The purpose of this study was to determine the incidence rate of prostate cancer among men with erectile dysfunction (ED) treated with phosphodiesterase type 5 inhibitors (PDE-5i) over a 7-year period vs. men with ED of the same age and with similar risk factors who were not treated with PDE-5i. In a retrospective review of electronic medical records and billing databases between the years 2000 and 2006, men with ED between the ages of 50 and 69 years and no history of prostate cancer prior to 2000 were identified. These individuals were divided into two groups: 2362 men who had treatment with PDE-5i, and 2612 men who did not have treatment. Demographic data in each group were compared. During the study period, 97 (4.1%) men with ED treated with PDE-5i were diagnosed with prostate cancer compared with 258 (9.9%) men with ED in the non-treated group (P<00001). A higher percentage of African Americans were treated with PDE-5i vs. those who were not (10.5% vs. 7.1% P<0.0001). The PDE-5i group had lower documented diagnosis of elevated prostate-specific antigen (10.0% vs. 13.1% P=0.0008) and higher percentage of benign prostatic hyperplasia (38.4% vs. 35.1% P=0.0149). Men with ED treated with PDE-5i tended to have less chance (adjusted odds ratio: 0.4; 95% confidence intervals: 0.3–0.5; P<0.0001) of having prostate cancer. Our data suggest that men with ED treated with PDE-5i tended to have less of a chance of being diagnosed with prostate cancer. Further research is warranted. 相似文献
8.
Ahmed I El-Sakka 《Asian journal of andrology》2013,15(4):492-496
Our aim was to assess the impact of the association between elevated oestradiol (E2) and low testosterone (T) levels on erectile dysfunction (ED) severity. A total of 614 male patients with ED and a normal or low T level in association with normal or elevated E2 levels were enrolled. Patients underwent routine laboratory investigations in addition to measurements of total T, total E2, follicle-stimulating hormone (FSH), luteinizing hormone (LH) and prolactin. We compared the responses to the erectile function domain, Q3 (achieving erection) and Q4 (maintaining erection) of the International Index for Erectile Function (IIEF) score in patients with the following: normal T and E2 levels; low T level; low T level and elevated E2 level; and elevated E2 level. Of the patients included, 449 (73.1%) had normal T and E2 levels, 110 (17.9%) had a low T level, 36 (5.9%) had a low T level and an elevated E2 level, and 19 (3.1%) had an elevated E2 level. Increased ED severity was significantly associated with low T levels, elevated E2 levels, and both a low T level and an elevated E2 level. Additionally, the mean values of the EF-domain, Q3 and Q4 were significantly lower in patients with both a low T level and an elevated E2 level compared to patients with any condition alone. In conclusion, a low T level had the primary effect on erectile function; however, a concomitantly elevated E2 level had an additive impairment effect. 相似文献
9.
《Vaccine》2015,33(21):2470-2476
Background/objectivesAnthrax vaccine adsorbed (AVA, BioThrax®) is recommended for post-exposure prophylaxis administration for the US population in response to large-scale Bacillus anthracis spore exposure. However, no information exists on AVA use in children and ethical barriers exist to performing pre-event pediatric AVA studies. A Presidential Ethics Commission proposed a potential pathway for such studies utilizing an age de-escalation process comparing safety and immunogenicity data from 18 to 20 year-olds to older adults and if acceptable proceeding to evaluations in younger adolescents. We conducted exploratory summary re-analyses of existing databases from 18 to 20 year-olds (n = 74) compared to adults aged 21 to 29 years (n = 243) who participated in four previous US government funded AVA studies.MethodsData extracted from studies included elicited local injection-site and systemic adverse events (AEs) following AVA doses given subcutaneously at 0, 2, and 4 weeks. Additionally, proportions of subjects with ≥4-fold antibody rises from baseline to post-second and post-third AVA doses (seroresponse) were obtained.ResultsRates of any elicited local AEs were not significantly different between younger and older age groups for local events (79.2% vs. 83.8%, P = 0.120) or systemic events (45.4% vs. 50.5%, P = 0.188). Robust and similar proportions of seroresponses to vaccination were observed in both age groups.ConclusionsAVA was safe and immunogenic in 18 to 20 year-olds compared to 21 to 29 year-olds. These results provide initial information to anthrax and pediatric specialists if AVA studies in adolescents are required. 相似文献
10.
Diana L. Vork Terry D. Schneekloth Adam C. Bartley Lisa E. Vaughan Maria I. Lapid Sheila G. Jowsey-Gregoire Ziad M. El-Zoghby Sandra M. Herrmann Cheryl L. Tran Robert C. Albright LaTonya J. Hickson 《Mayo Clinic proceedings. Mayo Clinic》2018,93(3):321-332